ALLMedicine™ Acid Phosphatase Center
Research & Reviews 1,175 results
https://doi.org/10.1016/j.ecoenv.2023.114762
Ecotoxicology and Environmental Safety; Sang ZW, Bao MN et. al.
Mar 18th, 2023 - Acid phosphatase(ACP) is an important immune enzyme in crustacean humoral immunity. At present, the research on ACP mainly focuses on the biochemical properties of the enzyme, while few studies on gene expression. In this study, ShACP was cloned a...
https://doi.org/10.1016/j.dci.2023.104678
Developmental and Comparative Immunology; Sun L, Lin F et. al.
Mar 13th, 2023 - The giant freshwater prawn (Macrobrachium rosenbergii) is a commercially valuable freshwater crustacean species that frequently appears a death affected by various diseases, resulting in substantial economic losses. Improving the survival rate of ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001663
International Journal of Environmental Research and Publi... Mackiewicz-Walec E, Krzebietke SJ et. al.
Mar 12th, 2023 - Soil-dwelling microorganisms play an important role in the environment by decomposing organic matter, degrading toxic compounds and participating in the nutrient cycle. The microbiological properties of soil are determined mainly by the soil pH, g...
https://doi.org/10.1039/d2fo02938c
Food & Function; Ye Y, Xu X et. al.
Mar 8th, 2023 - Periodontitis is a chronic inflammatory disease induced by subgingival microbial dysbiosis, characterised by inflammation of the soft tissues of the periodontium and progressive loss of alveolar bone. Limosilactobacillus fermentum CCFM1139 is a pr...
https://doi.org/10.1007/s10787-023-01158-4
Inflammopharmacology Bakry SM, Naser AFA et. al.
Feb 26th, 2023 - Bioactivity-guided fractionation of F. drupacea Thunb. extract revealed that the water fraction (FDWF) increased pH of the artificial gastric juice from 1.2 to 5.67 ± 0.015. The gastroprotective effect of FDWF against ulcer induced by ethanol was ...
Drugs 3 results see all →
Clinicaltrials.gov 26 results
https://clinicaltrials.gov/ct2/show/NCT05735197
Feb 21st, 2023 - All patients have been recruited from the renal clinic of Nephrology and transplantation unit. The entire study will be conducted at Urology and Nephrology center in Mansoura University. Study design and sample size: • Sample size: Was calculated ...
https://clinicaltrials.gov/ct2/show/NCT05553639
Feb 3rd, 2023 - This is a first-in-human Phase 1/2, multinational, multicenter, open-label study of HB-302/HB-301 alternating 2-vector therapy in participants with metastatic castration-resistant prostate cancer (mCRPC) comprising 2 phases: a Phase 1 Dose Escalat...
https://clinicaltrials.gov/ct2/show/NCT05704088
Jan 30th, 2023 - Study sitting: Nephrology and renal transplant unit at urology and nephrology center in Mansoura University. Study design and sample size: Randomized, controlled trial that will include 100 patients with Lupus nephritis (LN) with an estimated glom...
https://clinicaltrials.gov/ct2/show/NCT05692297
Jan 25th, 2023 - Objective: To verify the efficacy and safety of denosumab in the prevention and treatment of CKD-MBD in CKD patients with high risk of fracture. Methods: A cohort of CKD patients with high risk of fracture was established and followed up for long ...
https://clinicaltrials.gov/ct2/show/NCT02499835
Dec 1st, 2022 - PRIMARY OBJECTIVES: I. To evaluate the safety of pembrolizumab in combination with pTVG-HP (pTVG-HP plasmid DNA vaccine) in patients with castration-resistant, metastatic prostate cancer. II. To determine the 6-month progression-free survival and ...
News 57 results
https://www.medscape.com/viewarticle/983376
Nov 2nd, 2022 - Since antiquity, physicians have used their senses to study and try to understand human health and disease. Sight, sound, touch, smell, and taste. For much of history and for most physician-clinicians today, those five senses, when used well, are ...
https://www.onclive.com/view/immunotherapeutics-aim-for-larger-role-in-prostate-cancer
Jun 29th, 2022 - Highly effective tools, such as immunotherapeutic agents, have emerged for the treatment of patients with a wide range of malignancies. However, they have demonstrated relatively limited benefit in the treatment of patients with prostate cancer. I...
https://www.onclive.com/view/ipcc_prostate_cancer
Mar 15th, 2022 - Click here to view as PDF. The Third Annual Interdisciplinary Prostate Cancer Congress (IPCC) took place March 27 in New York, New York. ArcMesa Educators organized the event, which was open to urologists, radiologists, and medical oncologists. S...
https://www.onclive.com/view/immune-correlates-may-indicate-responsiveness-to-ipilimumab-in-mcrpc
Oct 6th, 2021 - Sumit Subudhi, MD, PhD A subset of patients with metastatic castration-resistant prostate cancer (mCRPC) who have low tumor mutational burden (TMB) may benefit from checkpoint inhibition with ipilimumab (Yervoy) if the tumor has a high density of...
https://www.onclive.com/view/vogelzang-disputes-weak-guideline-rating-for-sipuleucel-t
Oct 6th, 2021 - Nicholas J. Vogelzang, MD In a recent guideline for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC), the American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO) shared their thoughts on the imp...